Protreome analysis for pathogenicity and new diagnostic markers for Aspergillus fumigatus

Medical Mycology

Volumn 47, Issue SUPPL. 1, 2009, Pages

  Kniemeyer, Olaf ^a,b   Lessing, Franziska ^a,b   Brakhage, Axel A ^a,b  

^a HANS KNÖLL INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

2D gel electrophoresis; Aspergillus fumigatus; Diagnosis; Fungal proteomics

Indexed keywords

CATALASE; FUNGAL PROTEIN; HEAT SHOCK PROTEIN; HYDROGEN PEROXIDE; PROTEIN AFYAP1; PROTEIN ASPF3; PROTEIN YAP1; PROTEIN YAP1P; PROTEOME; REACTIVE OXYGEN INTERMEDIATE; REACTIVE OXYGEN METABOLITE; SACCHAROMYCES CEREVISIAE PROTEIN; THIOREDOXIN PEROXIDASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; FUNCTIONAL PROTEOMICS; FUNGAL DETECTION; FUNGAL VIRULENCE; GEL ELECTROPHORESIS; GENE EXPRESSION; IMMUNOCOMPROMISED PATIENT; INNATE IMMUNITY; INVASIVE ASPERGILLOSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROARRAY ANALYSIS; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; CHEMISTRY; GENE EXPRESSION REGULATION; PATHOGENICITY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; REVIEW;

ASPERGILLUS FUMIGATUS; FUNGI; SACCHAROMYCES CEREVISIAE;

ASPERGILLUS FUMIGATUS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; PROTEOME; STRESS, PHYSIOLOGICAL; VIRULENCE FACTORS;

EID: 67651112220     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802169138     Document Type: Article

References (55)

1. Wilkins MR, Sanchez JR, Gooley AA, et al. Progress with proteome projects, why all proteins expressed by a genome should be identified and how to do it. Biotech Gen Eng Reviews 1995; 13: 19-50.
2. Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004; 4: 3665-3685.
3. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003; 422: 198-207.
4. Phizicky E, Bastiaens PIH, Zhu H, Snyder M, Fields S. Protein analysis on a proteomic scale. Nature 2003; 422: 208-215.
5. Zhu H, Bilgin M, Snyder M. Proteomics. Annu Rev Biochem 2003; 72 783-812.
6. De Hoog CL, Mann M. Proteomics. Annu Rev Genomics Hum Genet 2004; 5: 267-29
7. Nierman WC, Pain A, Anderson MJ, Wortman JR, et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 2005; 438: 1151-1156.
8. Odds FC, Gow NAR, Brown AJP. Fungal virulence studies come of age. Genome Biol 2001; 2: 1009.1-1009.4.
9. Brakhage AA. Systemic fungal infections caused by Aspergillus species: Epidemiology, infection process and virulence determinants. J Curr Drug Targets 2005; 6: 875-886.
10. Fung ET, Wright Gl Jr, Dalmasso EA. Proteomic strategies for biomarker identification: Progress and challenges. Curr Opin Mol Ther 2000; 2: 643-650.
11. Seliger B, Kellner R. Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets. Proteomics 2002; 2: 1641-1651.
12. Carberry S, Doyle S. Proteomic studies in biomedically and industrially relevant fungi. Cytotechnology 2007; 53: 95-100.
13. Kim Y, Nandakumar MP, Marten MR. Proteomics of filamentous fungi. Trends Biotechnol 2007; 25: 395-400.
14. Kim Y, Nandakumar MP, Marten MR. The state of proteome profiling in the fungal genus Aspergillus. Brief Funct Genom Proteom 2008; 7: 87-94.
15. Kniemeyer O, Brakhage AA. Proteomics and its application to the human-pathogenic fungi Aspergillus fumigatus and Candida albicans. In: Brakhage AA, Zipfel PF (eds). The Mycota VI- Human and Animal Relationships. Berlin; Springer, 2008, in press.
16. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 2007; 45: 321-346.
17. Kniemeyer O, Lessing F, Scheibner O, Hertweck C, Brakhage AA. Optimisation of a 2-D gel electrophoresis protocol for the human-pathogenic fungus Aspergilllus fumigatus. Curr Genet 2006; 49: 178-189.
18. Carberry S, Neville CM, Kavanagh KA, Doyle S. Analysis of major intracellular proteins of Aspergillus fumigatus by MALDI mass spectrometry: Identification and characterisation of an elongation factor 1B protein with glutathione transferase activity. Biochem Biophys Res Commun 2006; 341: 1096-1104.
19. Bruneau JM, Magnin T, Tagat E, et al. Proteome analysis of Aspergillus fumigatus identifies glycosylphosphatidylinositolanchored proteins associated to the cell wall biosynthesis. Electrophoresis 2001; 22: 2812-2823.
20. Asif AR, Oellerich M, Amstrong VW, et al. Proteome of conidial surface associated proteins of Aspergillus fumigatus reflecting potential vaccine candidates and allergens. J Proteome Res 2006; 5 954-962.
21. Kim KH, Brown KM, Harris PV, Langston JA, Cherry JR. A proteomic strategy to discover b-glucosidases from Aspergillus fumigatus with two-dimensional page in-gel activity assay and tandem mass spectrometry. J Proteome Res 2007; 6: 4749-4759.
22. Philippe B, Ibrahim-Granet O, Prevost MC, et al. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 2003; 71: 3034-3042.
23. Bonnett CR, Cornish EJ, Harmsen AG, Burrit JB. Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus conidia. Infect Immun 2006; 74: 6528-6539.
24. Diamond RD, Clark RA. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun 1982; 38: 487-495.
25. Levitz SM, Farrell TP. Human neutrophil degranulation stimulated by Aspergillus fumigatus. J Leucocyt Biol 1990; 47: 170-175.
26. Aguirre J, Hansberg W, Navarro R. Fungal response to reactive oxygen species. Med Mycol 2006; 44: S101-S107.
27. Lessing F, Kniemeyer O, Wozniok I, et al. The Aspergillus fumigatus transcriptional regulator AfYap1 represents the major regulator for defense against reactive oxygen intermediates but is dispensable for pathogenicity in an intranasal mouse model. Eukaryot Cell 2007; 6: 2290-2302.
28. Reichenberger F, Habicht JM, Gratwohl A, Tamm M. Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patiens. Eur Respir J 2002; 19: 743-755.
29. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609-622.
30. De Repentigny L, Kilanowski E, Pedneault L, Boushira M. Immunoblot analyses of the serologic response to Aspergillus fumigatus antigens in experimental invasive aspergillosis. J Infect Dis 1991; 163: 1305-1311.
31. López-Medrano R, Ovejero MC, Calera JA, Puente P, Leal F. Aspergillus fumigatus antigens. Microbiology 1995; 141: 2699-2704.
32. Shen HD, Lin WL, Tam FM, et al. Identification of vacuolar serine proteinase as a major allergen of Aspergillus fumigatus by immunoblotting and N-terminal amino acid sequence analysis. Clin Exp Allergy 2001; 31: 295-302.
33. Lai HY, Tam MF, Tang RB, et al. cDNA cloning and immunological characterization of a newly identified enolase allergen from Penicillium citrinum and Aspergillus fumigatus. Int Arch Allergy Immunol 2002; 127: 181-190.
34. Gautam P, Sundaram CS, Madan T, et al. Identification of novel allergens of Aspergillus fumigatus using immunoproteomics approach. Clin Experiment Allergy 2007; 37: 1239-1249.
35. Crameri R. Epidemiology and molecular basis of the involvement of Aspergillus fumigatus in allergic disease. Contrib Microbiol 1999; 2: 44-56.
36. Kurup VP. Aspergillus antigens: Which are important? Med Mycol 2005; 43: S189-S196.
37. Bowyer P, Denning DW. Genomic analysis of allergen genes in Aspergillus spp.: The relevance of genomics to everyday research. Med Mycol 2007; 45: 17-26.
38. Bowyer P, Blightman O, Denning DW. Relative reactivity of Aspergillus allergens used in serological tests. MedMycol 2006; 44: S23-S28.
39. Maertens J, Van Eldere J, Verhaegen J, et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186 1297-1306.
40. Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukaemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 1999-2205.
41. Holdom MD, Lechenne B, Hay RJ, Hamilton AJ, Monod M. Production and characterization of recombinant Aspergillus fumigatus Cu,Zn superoxide dismutase and its recognition by immune human sera. J Clin Microbiol 2000; 38: 558-562.
42. Weig M, Frosch M, Tintelnot K, et al. Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus associated diseases. J Clin Microbiol 2001; 39: 1721-1730.
43. Schwienbacher M, Weig M, Thies S, Regula JT, Heesemann J, Ebel F. Analysis of the major proteins secreted by the human opportunistic pathogen Aspergillus fumigatus under in vitro conditions. Med Mycol 2005; 43: 623-630.
44. Sarfati J, Monod M, Recco P, et al. Recombinant antigens as diagnostic markers for aspergillosis. Diagn Microbiol Infect Dis 2006; 55: 279-291.
45. Meersseman W, Vandecasteele SJ, Wilmer A, et al. Invasive aspergillosis in critically ill patients without malignancy. Amer J Respir Crit Car Med 2004; 170: 621-625.
46. Bozza S, Gaziano R, Lipford GB, et al. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect 2002; 4 1281-1290.
47. Ito JI, Lyoins JM, Hong TB, et al. Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis. Infect Immun 2006; 74: 5075-5084.
48. Pitarch A, Jiménez A, César Nombela, Gil C. Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses. Mol Cell Proteomics 2006; 5: 79-96
49. Hutchens TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993; 7: 576-580.
50. Kiehntopf M, Siegmund R, Deufel T. Application of SELDITOF-mass spectrometry for biomarker identification: Potentials and limitations. J Lab Med 2007; 31: 93-108.
51. Lescuyer P, Hochstrasser D, Rabillould T. How shall we use the proteomics toolbox for biomarker discovery? J Proteome Res 2007; 6: 3371-3376.
52. Hess JL, Blazer L, Romer T, et al. Immunoproteomics. J Chromat B 2005; 815: 65-75.
53. Sydor JR, Nock S. Protein expression profiling arrays: Tools for the multiplexed high-throughput analysis of proteins. Proteome Sci 2003; 1: 3.
54. Lueking A, Cahil DJ, Mullner S. Protein biochips: A new versatile platform technology for molecular medicine. Drug Discov Today 2005; 10: 789-794.
55. Stelter S, Angenendt P, Cahill DJ, et al. Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitides infections. Proteomics 2005; 5: 2048-2055.